Cargando…
Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats
Duvelisib (DUV) is a new oral phosphoinositide-3-kinase (PI3K)-δ and PI3K-γ inhibitor. It is used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This study describes the development and validation of a new highly sensitive and eff...
Autores principales: | Darwish, Ibrahim A., Alzoman, Nourah Z., Almomen, Aliyah, Almehizia, Abdulrahman A., Attwa, Mohamed W., Darwish, Hany W., Sayed, Ahmed Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999367/ https://www.ncbi.nlm.nih.gov/pubmed/36909770 http://dx.doi.org/10.1039/d3ra00310h |
Ejemplares similares
-
A Highly Sensitive Nonextraction-Assisted HPLC Method with Fluorescence Detection for Quantification of Duvelisib in Plasma Samples and its Application to Pharmacokinetic Study in Rats
por: Sayed, Ahmed Y, et al.
Publicado: (2021) -
Development and validation of a UPLC-MS/MS method for simultaneous detection of doxorubicin and sorafenib in plasma: Application to pharmacokinetic studies in rats
por: Altalal, Alanoud, et al.
Publicado: (2023) -
A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
por: Maher, Hadir M., et al.
Publicado: (2019) -
Development and validation of UPLC-MS/MS method for studying the pharmacokinetic interaction of dasabuvir and tamoxifen, 4-hydroxytamoxifen in Wistar rats
por: Almomen, Aliyah, et al.
Publicado: (2020) -
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways
por: Kadi, Adnan A., et al.
Publicado: (2018)